2009
DOI: 10.1016/s1098-3015(10)74296-0
|View full text |Cite
|
Sign up to set email alerts
|

Pcn45 Cost Comparison Between 90y Ibritumomab Tiuxetan Consolidation and Rituximab Maintenance Post-Chemotherapy in Naïve Patients With B-Cell Non-Hodgkin's Lymphoma in Spain

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles